Medicare Overpaid Hospitals $26 Million for IMRT Medicare Overpaid Hospitals $26 Million for IMRT
Medicare has inadvertently overpaid hospitals nearly $26 million for outpatient intensity-modulated radiation therapy (IMRT) planning services because of improper billing.Medscape Medical News
OBJECTIVE: To analyze the pattern of local failure in patients with nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT) and find a more reasonable delineation of the clinical target volume (CTV).METHODS AND MATERIALS: A total of 212 patients with non-metastatic NPC who underwent IMRT were analyzed. Radiation therapy was run at a total dose of 66-74 Gy (2.0-2.2 Gy fractions). The follow-up of local recurrence and the recurrence-related features were analyzed for the original treatment situation. The failures were delimited as “in-field failure” if Vrecur within the 95% isodose curve (V95...
Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors of the head and neck in Southeast Asia and southern China. Although the comprehensive treatment based on intensity-modulated radiation therapy improves outcomes, the five-year survival rate of NPC patients is low, and the recurrence remains high. Radiotherapy resistance is the main cause of poor prognosis in NPC patients. MicroRNAs (miRNAs) are a class of endogenous non-coding RNAs regulating various biological functions in eukaryotes. These miRNAs can regulate the development and progression of nasopharyngeal carcinoma by affecting the proliferation...
This study demonstrated that after the completion of 3-4 cycles of chemotherapy with a remission, concurrent chemoradiotherapy with oral etoposide and cisplatin improved survival compared with sequential chemoradiotherapy in LS-SCLC with bulky tumor. ClinicalTrials.gov Identifier: NCT01745445.
Radiation therapy remains an essential component of cancer therapy for millions of patients annually in the United States and globally. Radiation therapy involves the focal deposition of ionizing radiation (IR) to the tumor and surrounding at-risk tissue compartments such as regional lymph nodes. The most common treatment approaches include external beam radiation therapy (EBRT) using high-energy photons, electrons, or protons, as well as brachytherapy and radionuclide therapy. Significant technical advances in EBRT and diagnostic imaging over the past several decades have enabled more localized and precise dose deposition...
Target volume delineation has always been but has become increasingly challenging in radiation oncology given the ever more prevalent use of techniques such as 3D conformal radiation therapy and intensity-modulated radiation therapy (IMRT) that enable dose escalation while sparing adjacent normal tissue.
Conclusion: SRS/FRT remains a useful adjuvant for treatment of residual or recurrent ELSTs, where the risk of revision microsurgical resection is high.
ConclusionsBased on a Markov microsimulation analysis, both AI-alone and APBI-alone are appropriate options for patients 70 years or older with early breast cancer with small cost differences noted. A prospective trial comparing the approaches is warranted.
ConclusionAdjuvant hypofractionated prone breast IMRT has excellent locoregional control and minimal toxicity.
Conclusion: This analysis uses TDABC to estimate the relative internal costs of various RT strategies associated with treating oligometastatic NSCLC. This methodology will become increasingly relevant to each organization in context of the anticipated mandate of alternative/bundled payment models for radiation oncology by the Centers for Medicare and Medicaid Services. PMID: 32529054 [PubMed]
Nasopharyngeal carcinoma (NPC), also known as the “Canton tumor”, is one of the most common cancers in southern China. In Hong Kong, the Hong Kong Cancer Registry has noted that NPC was the 6th most common cancer in males with 599 new cases and an incidence rate of 17.7 in 100,000 in 2016. The mortality of NPC ranked 8th in male and 10th in bot h sexes . The first-line treatment for nasopharyngeal cancer is radiation therapy. Xerostomia is a common, debilitating complication of radiation therapy for nasopharyngeal carcinoma .